Trial intelligence / Profile preview

Menactra Post-Marketing Safety Study in the Philippines

NCT01270503Phase 4Completed

Sponsor
Sanofi
Start
Dec 2010
Primary completion
Dec 2013
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 4 trial of meningococcal A conjugate vaccine in meningococcal disease, sponsored by Sanofi. Started Dec 2010; status: completed.

02

Drugs

meningococcal A conjugate vaccine
03

Conditions

meningococcal disease

Beyond the preview

Go deeper on NCT01270503.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01270503.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call